HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Rollinson Selected Research

Schistosomiasis haematobia (Schistosomiasis haematobium)

11/2021Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study.
1/2021Impact of seven years of mass drug administration and recrudescence of Schistosoma haematobium infections after one year of treatment gap in Zanzibar: Repeated cross-sectional studies.
9/2020Analytical and Clinical Assessment of a Portable, Isothermal Recombinase Polymerase Amplification (RPA) Assay for the Molecular Diagnosis of Urogenital Schistosomiasis.
1/2020SCORE Operational Research on Moving toward Interruption of Schistosomiasis Transmission.
1/2019Evaluation of integrated interventions layered on mass drug administration for urogenital schistosomiasis elimination: a cluster-randomised trial.
1/2019Correction to: Urogenital schistosomiasis elimination in Zanzibar: accuracy of urine filtration and haematuria reagent strips for diagnosing light intensity Schistosoma haematobium infections.
10/2018Urogenital schistosomiasis elimination in Zanzibar: accuracy of urine filtration and haematuria reagent strips for diagnosing light intensity Schistosoma haematobium infections.
1/2018The small RNA complement of adult Schistosoma haematobium.
1/2016Praziquantel coverage in schools and communities targeted for the elimination of urogenital schistosomiasis in Zanzibar: a cross-sectional survey.
11/2013Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Rollinson Research Topics

Disease

26Infections
11/2021 - 01/2007
24Schistosomiasis (Bilharziasis)
09/2022 - 01/2006
19Schistosomiasis haematobia (Schistosomiasis haematobium)
11/2021 - 02/2006
7Schistosomiasis mansoni
09/2022 - 02/2006
3Neglected Diseases
01/2022 - 06/2014
3Reinfection
01/2015 - 11/2013
3Coinfection
01/2015 - 11/2013
2Helminthiasis (Helminthiases)
12/2009 - 01/2008
1Tuberculosis (Tuberculoses)
11/2018
1Paragonimiasis
11/2018
1Persistent Infection
01/2015
1Imported Communicable Diseases
11/2013
1Trichuriasis
12/2010
1Exanthema (Rash)
06/2010
1Headache (Headaches)
06/2010
1Vomiting
06/2010
1Urticaria (Hives)
06/2010
1Strongyloidiasis
05/2010
1Ascariasis
05/2010
1Anemia
05/2010
1Albuminuria
10/2009
1Inflammation (Inflammations)
12/2008
1Parasitic Diseases (Parasitic Disease)
05/2004

Drug/Important Bio-Agent (IBA)

15Praziquantel (Biltricide)FDA Link
01/2022 - 01/2006
6Reagent StripsIBA
09/2020 - 10/2007
5AntigensIBA
11/2021 - 02/2006
3Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2008
3Complement System Proteins (Complement)IBA
05/2020 - 02/2006
3EnzymesIBA
05/2010 - 12/2008
2Biomarkers (Surrogate Marker)IBA
11/2021 - 10/2012
2AntibodiesIBA
11/2021 - 01/2013
2Albendazole (Albenza)FDA Link
01/2018 - 12/2010
2RNA (Ribonucleic Acid)IBA
01/2018 - 05/2004
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 11/2013
2VaccinesIBA
12/2015 - 01/2006
2ImmunosorbentsIBA
05/2010 - 07/2009
2AlbuminsIBA
10/2009 - 08/2009
2Uridine Triphosphate (UTP)IBA
10/2009 - 08/2009
1ElementsIBA
09/2022
1Amantadine (Aman)FDA LinkGeneric
09/2022
1Recombinases (Recombinase)IBA
09/2020
1A-Form DNA (A-DNA)IBA
11/2018
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
11/2018
1NiclosamideFDA Link
01/2018
1Indicators and Reagents (Reagents)IBA
04/2017
1Phosphotransferases (Kinase)IBA
06/2014
1locked nucleic acidIBA
11/2013
1AnthelminticsIBA
04/2011
1Mebendazole (Anti-Worm)FDA Link
12/2010
1Ivermectin (Mectizan)FDA Link
12/2010
1CreatinineIBA
08/2009
1PolyaminesIBA
12/2008
1Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
12/2008
1copineIBA
12/2008
1Free RadicalsIBA
12/2008
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2008
1Peptide Elongation Factor 1 (EF-1)IBA
12/2008
1Peptide Elongation Factor 2 (EF-2)IBA
12/2008
1Karyopherins (Importin)IBA
12/2008
1Cathepsin LIBA
12/2008
1Cysteine Proteases (Cysteine Protease)IBA
12/2008
1SoilIBA
11/2008
1AntioxidantsIBA
01/2007
1ArtemetherFDA Link
01/2006

Therapy/Procedure

15Drug Therapy (Chemotherapy)
01/2022 - 01/2008
12Mass Drug Administration
01/2022 - 12/2014
2Aftercare (After-Treatment)
11/2013 - 06/2010
1Therapeutics
11/2018
1Activities of Daily Living (ADL)
01/2016
1Lasers (Laser)
01/2013